• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉搭桥手术患者中肝素涂层与非涂层体外循环的比较。

Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.

作者信息

Oliver William C, Nuttall Gregory A, Ereth Mark H, Santrach P J, Buda Daniel A, Schaff Hartzell V

机构信息

Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

J Cardiothorac Vasc Anesth. 2003 Apr;17(2):165-70. doi: 10.1053/jcan.2003.41.

DOI:10.1053/jcan.2003.41
PMID:12698396
Abstract

OBJECTIVE

To assess the effect of heparin-coated circuits on bleeding, transfusion, and platelet count in patients undergoing primary coronary artery bypass grafting with full heparinization.

DESIGN

Randomized, double-blind study.

SETTING

Tertiary-care academic medical center.

PARTICIPANTS

Eighty-eight patients undergoing coronary artery bypass grafting requiring cardiopulmonary bypass (CPB) without previous sternotomy.

INTERVENTIONS

Subjects received either a heparin-coated or an uncoated extracorporeal circuit for CPB. Heparin, 300 micro/kg, was administered, and supplemental amounts were administered to maintain an activated coagulation time of greater than 480 seconds. Platelet counts were determined during CPB. Mediastinal chest tube drainage was collected in the intensive care unit for 24 hours.

MEASUREMENTS AND MAIN RESULTS

The mean platelet counts were similar between the groups during CPB. There was no significant difference in 24-hour mediastinal chest tube drainage (mean +/- standard deviation; median) between the heparin-coated (n = 44, 1096 +/- 401, 1015 mL) and uncoated group (n = 44, 1150 +/- 548, 1040 mL; p = 0.91). The heparin-coated group received less allogeneic packed red blood cells (0.9 +/- 1.6, 0.0 v 1.5 +/- 1.8, 1.0 U; p = 0.04).

CONCLUSIONS

The use of a heparin-coated or uncoated cardiopulmonary bypass circuit and full heparinization marginally reduced only red blood cell transfusion but was not associated with platelet sparing or reduced perioperative bleeding.

摘要

目的

评估肝素涂层回路对接受充分肝素化的初次冠状动脉搭桥术患者出血、输血及血小板计数的影响。

设计

随机双盲研究。

地点

三级医疗学术医学中心。

参与者

88例接受冠状动脉搭桥术且需要体外循环(CPB)且既往未行胸骨切开术的患者。

干预措施

受试者接受用于CPB的肝素涂层或未涂层体外回路。给予300微克/千克肝素,并给予补充剂量以维持活化凝血时间大于480秒。在CPB期间测定血小板计数。在重症监护病房收集纵隔胸管引流物24小时。

测量指标及主要结果

CPB期间两组的平均血小板计数相似。肝素涂层组(n = 44,1096±401,1015毫升)和未涂层组(n = 44,1150±548,1040毫升;p = 0.91)之间24小时纵隔胸管引流量无显著差异。肝素涂层组接受的异体浓缩红细胞较少(0.9±1.6,0.0对1.5±1.8,1.0单位;p = 0.04)。

结论

使用肝素涂层或未涂层的体外循环回路及充分肝素化仅略微减少了红细胞输血,但与血小板保护或围手术期出血减少无关。

相似文献

1
Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.冠状动脉搭桥手术患者中肝素涂层与非涂层体外循环的比较。
J Cardiothorac Vasc Anesth. 2003 Apr;17(2):165-70. doi: 10.1053/jcan.2003.41.
2
Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.肝素化体外循环和全量肝素剂量仅略微改善临床效果。
Ann Thorac Surg. 1996 Oct;62(4):1128-33. doi: 10.1016/0003-4975(96)00490-0.
3
Heparin-bonded cardiopulmonary bypass circuits reduce the rate of red blood cell transfusion during elective coronary artery bypass surgery.肝素结合型体外循环回路可降低择期冠状动脉搭桥手术期间红细胞输注率。
J Cardiothorac Vasc Anesth. 2005 Oct;19(5):608-11. doi: 10.1053/j.jvca.2005.07.003.
4
Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.在冠状动脉血运重建再次手术中,对基于透明质酸的肝素结合体外循环进行临床和生物材料评估,比较减少全身抗凝与完全全身抗凝的效果。
J Cardiovasc Med (Hagerstown). 2009 Feb;10(2):135-42. doi: 10.2459/JCM.0b013e32831eef9d.
5
Clinical use of heparin-coated cardiopulmonary bypass in coronary artery bypass grafting.
Thorac Cardiovasc Surg. 2001 Jun;49(3):131-6. doi: 10.1055/s-2001-14287.
6
A prospective, randomized platelet-function study of heparinized oxygenators and cardiotomy suction.肝素化氧合器与心内吸引器的前瞻性随机血小板功能研究。
J Cardiothorac Vasc Anesth. 2006 Aug;20(4):554-61. doi: 10.1053/j.jvca.2006.01.021. Epub 2006 Apr 27.
7
Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.肝素涂层体外循环回路在左心室功能不全的冠心病患者中的生物相容性优于聚甲基丙烯酸甲酯涂层回路。
J Card Surg. 2006 Nov-Dec;21(6):572-7. doi: 10.1111/j.1540-8191.2006.00298.x.
8
Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.体外循环对单肺移植术后早期移植肺功能的有害影响:肝素涂层体外循环回路的评估
J Heart Lung Transplant. 1994 May-Jun;13(3):498-507.
9
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.术前接受依诺肝素治疗的冠状动脉手术患者的肝素抵抗和血小板活化增加。
Eur J Cardiothorac Surg. 2006 Jun;29(6):933-40. doi: 10.1016/j.ejcts.2006.02.007. Epub 2006 May 3.
10
Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.氨甲环酸与抑肽酶在心脏初次手术中的应用:对220例接受氨甲环酸或抑肽酶治疗的心脏手术患者的分析
Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b.